Catalent | CTLT - Laba Kotor Pada Penjualan



Laba Kotor Pada Penjualan Perubahan Tanggal
Agilent USD 990M 44M 2026-03
AstraZeneca USD 12.61B 225M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Bruker USD 379.8M 69.4M 2026-03
Centene USD 5.26B 3.12B 2026-03
Charles River Laboratories USD 279.32M 7.36M 2026-03
Cigna USD 6.08B 50.37B 2026-03
Danaher USD 3.59B 375M 2026-03
Dentsply International USD 427M 16M 2026-03
Elevance Health USD 11.68B 889M 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Glaxosmithkline GBP 8.75B 2.92B 2025-09
Humana USD 4.82B 754M 2025-06
Illumina USD 721M 38M 2026-03
Intuitive Surgical USD 1.83B 73.8M 2026-03
IQVIA Holdings USD 1.07B 52M 2026-03
J&J USD 17.24B 642M 2026-03
Laboratory Of America USD 1.01B 20.6M 2026-03
Lonza CHF 1.29B 248M 2025-06
McKesson USD 3.68B 143M 2025-12
Merck EUR 3.07B 104M 2026-03
Merck USD 10.85B 2.57B 2025-12
Mettler Toledo International USD 675.44M 65.98M 2025-12
Novartis USD 10.07B 184M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Quest Diagnostics USD 906M 33M 2026-03
Repligen USD 108.28M 4.45M 2026-03
Revvity USD 387.66M 34M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
Supernus Pharmaceuticals USD 129.36M 34.68M 2026-03
Thermo Fisher Scientific USD 4.49B 146M 2026-03
UnitedHealth USD 18.49B 2.14B 2025-12
Veradigm USD 83.44M 3.95M 2022-09
Waters USD 542M 15.42M 2026-03
West Pharmaceutical Services USD 296.4M 7.5M 2026-03